| Literature DB >> 33828855 |
Christian Smith1, Razi Zaidi1, Jagmeet Bhamra1, Anna Bridgens2, Caesar Wek1, Michail Kokkinakis2.
Abstract
Subtalar arthroereisis has a controversial history and has previously been associated with high failure rates and excessive complications.A database search for outcomes of arthroereisis for the treatment of symptomatic paediatric flexible pes planus provided 24 articles which were included in this review, with a total of 2550 feet operated on.Post-operative patient-reported outcome measures recorded marked improvement. Patient satisfaction was reported as excellent in 79.9%, and poor in 5.3%. All radiological measurements demonstrated improvement towards the normal range following arthroereisis, as did hindfoot valgus, supination, dorsiflexion and Viladot grade.Complications were reported in 7.1% of cases, with a reoperation rate of 3.1%.Arthroereisis as a treatment for symptomatic paediatric flexible pes planus produces favourable outcomes and high patient satisfaction rates with a reasonable risk profile. There is still a great deal of negativity and literature highlighting the complications and failures of arthroereisis, especially for older implants.The biggest flaws in the collective literature are the lack of high-quality prospective studies, a paucity of long-term data and the heterogeneity of utilized outcome measures between studies. Cite this article: EFORT Open Rev 2021;6:118-129. DOI: 10.1302/2058-5241.6.200076.Entities:
Keywords: arthroereisis; flatfoot; flexible; paediatric; pes planus
Year: 2021 PMID: 33828855 PMCID: PMC8022013 DOI: 10.1302/2058-5241.6.200076
Source DB: PubMed Journal: EFORT Open Rev ISSN: 2058-5241
Description of radiological measurements relevant to pes planus
| Measurement | Descripition | Normal range |
|---|---|---|
| Talonavicular coverage angle | The angle formed between a line connecting the edges of the articular surface of the talus and the articular surface of the navicular | 0° to 7° |
| Antero-posterior talar–1st metatarsal angle | The angle formed from a line through the mid-axis of the talus and the long axis of the 1st metatarsal | 3° to 11° |
| Lateral talar–1st metatarsal angle (Meary’s angle) | The angle formed from the bisection of the long axis of the talus and the 1st metatarsal | 2° to 10° |
| Calcaneal inclination | The angle formed between a line from the plantar surface of the calcaneus to the inferior distal articular surface and the transverse plan | 13° to 23° |
| Talar declination | The angle formed between a line drawn along the long axis of the talus and the transverse plane | 18° to 24° |
| Lateral talocalcaneal angle | The angle formed between a line bisecting the talus and a line from the plantar surface of the calcaneus to the inferior distal articular surface | 25° to 45° |
| Moreau-Costa-Bartani angle | The angle formed between a line from the inferior posterior calcaneal tuberosity to the inferior border of the talonavicular joint and a line from the medial sesamoid to the inferior border of the talonavicular joint | 115° to 125° |
| Antero-posterior talocalcaneal angle (Kite’s angle) | The angle formed by a line bisecting the head and neck of the talus and a line along the lateral surface of the calcaneus | 15° to 27° |
| Cyma line | A line drawn along the talonavicular joint and calcaneocuboid joint | Smooth double curve |
Fig. 1Radiological measurements from a weight-bearing lateral foot radiograph. Lateral talar 1st metatarsal angle: red (A); Calcaneal inclination: yellow (B); Lateral talocalcaneal angle: green (C); Moreau-Costa-Bartani angle: blue (D); Talar declination; pink (E).
Fig. 2Radiological measurements from a weight-bearing antero-posterior (AP) foot radiograph. Talonavicular coverage angle: yellow (A); AP talar 1st metatarsal angle: red (B); AP talocalcaneal angle: blue (C).
Fig. 3PRISMA flow diagram for the results of the search strategy.
Source: Reproduced from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097.
Articles included in this study
| Author | Year | Journal | Study design | Level of evidence |
|---|---|---|---|---|
| Giannini et al[ | 2001 | Retrospective case series | IV | |
| Jerosch et al[ | 2009 | Retrospective case series | IV | |
| Scharer et al[ | 2010 | Retrospective case series | IV | |
| Kellerman et al[ | 2011 | Prospective case series | IV | |
| Pavone et al[ | 2013 | Retrospective case series | IV | |
| Richter et al[ | 2013 | Prospective case series | IV | |
| De Pellegrin et al[ | 2014 | Retrospective case series | IV | |
| Chong et al[ | 2015 | Prospective, non-randomized comparative | IIB | |
| Martinelli et al[ | 2018 | Retrospective case series | IV | |
| Cao et al[ | 2017 | Retrospective case series | IV | |
| Das et al[ | 2017 | Prospective case series | IV | |
| Giannini et al[ | 2017 | Retrospective case series | IV | |
| Arbab et al[ | 2018 | Retrospective case series | IV | |
| Caravaggi et al[ | 2018 | Prospective, non-randomized comparative | IIB | |
| Memeo et al[ | 2019 | Retrospective, non-randomized comparative | III | |
| De Bot et al[ | 2019 | Retrospective case series | IV | |
| Ruiz-Picazo et al[ | 2019 | Retrospective case series | IV | |
| Megremis & Megremis[ | 2019 | Retrospective case series | IV | |
| Papamerkouriou et al[ | 2019 | Prospective case series | IV | |
| Hagen et al[ | 2019 | Prospective case series | IV | |
| Bernasconi et al[ | 2020 | Retrospective comparative | IV | |
| Indino et al[ | 2020 | Retrospective case series | IV | |
| Kubo et al[ | 2020 | Retrospective comparative | IV | |
| Franz et al[ | 2020 | Prospective case-control | III |
Downs and Black score of methodological quality for included studies. Y = positive result; N = negative result; ? = indeterminate result (counted as negative)
| Author | Objective described | Outcome described | Exclusion criteria described | Intervention described | Main findings reported | Adverse events | Random variability | Probability values | Representative sample invited to participate | Representative sample included | Lack of data dredging | Use of appropriate statistic | Accurate outcome measure | Confounders accounted for | Power calculation | Number of criteria met |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Giannini et al, 2001[ | Y | Y | N | Y | Y | Y | Y | Y | ? | ? | Y | Y | Y | Y | N | 11 |
| Jerosch et al 2009[ | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 13 |
| Scharer et al, 2010[ | Y | Y | N | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | N | 12 |
| Kellerman et al, 2011[ | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | N | 13 |
| Pavone et al, 2013[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 14 |
| Richter et al, 2013[ | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | N | 13 |
| De Pellegrin et al, 2014[ | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 13 |
| Chong et al, 2015[ | Y | Y | Y | N | Y | Y | N | Y | Y | Y | Y | Y | N | Y | N | 11 |
| Martinelli et al, 2018[ | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | N | Y | N | Y | N | 11 |
| Cao et al, 2017[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 14 |
| Das et al, 2017[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 14 |
| Giannini et al, 2017[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 14 |
| Arbab et al, 2018[ | Y | Y | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | Y | N | 12 |
| Caravaggi et al, 2018[ | Y | Y | Y | N | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | N | 12 |
| Memeo et al, 2019[ | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | N | 12 |
| De Bot et al, 2019[ | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | N | Y | Y | 13 |
| Ruiz-Picazo et al, 2019[ | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | N | 13 |
| Megremis & Megremis, 2019[ | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 13 |
| Papamerkouriou et al, 2019[ | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | N | 12 |
| Hagen et al, 2019[ | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | N | 13 |
| Bernasconi et al, 2020[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | N | 13 |
| Indino et al, 2020[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | N | Y | Y | 13 |
| Kubo et al, 2020[ | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 14 |
| Franz et al, 2020[ | Y | Y | Y | N | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | N | 12 |
Study data extracted from included articles in this review
| Author | No of patients | No of feet | Male: Female | Mean age at surgery | Age range | Implant manufacturer | Implant placement | Implant material | Bioresorbable | Concomitant procedures | Postoperative mobilization | Mean follow up / months | Routine implant removal | Timing of implant removal |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Giannini et al[ | 21 | 21 | 8–15 | Stryker | ST | PLLA | Y | TA = 6, AN = 12 | WB 3/52 | 48 | N | |||
| Jerosch et al[ | 18 | 21 | 13:5 | 11.9 | 8–14 | C | SS/Ti | N | TA = 5 | FWB | 31 | Y | SM | |
| Scharer et al[ | 39 | 68 | 24:15 | 12.0 | 6–16 | MBA | ST | Ti | N | TA = 18, AN = 4 | 24 | N | ||
| Kellerman et al[ | 25 | 43 | 18:7 | 10.0 | 7–14 | Bonestar | T | SS/Ti | N | None | FWB | 9 | Y | F |
| Pavone et al[ | 242 | 410 | 157:85 | 11.0 | 7–14 | Synthes | C | SS | N | TA = 18 | FWB | Y | 36/12 | |
| Richter et al[ | 18 | 31 | 8:10 | 10.6 | 8–12 | C | SS/Ti | N | TA = 25 | PWB 6/52 | 24 | Y | 24/12 | |
| De Pellegrin et al[ | 485 | 732 | 267:218 | 11.5 | 5–17 | Synthes | C | SS | N | PWB 5/7 | 54 | Y | 37/12 | |
| Chong et al[ | 7 | 13 | 12.8 | 8–17 | Vilex | ST | Ti | N | None | WC 3/52 | 12.9 | N | ||
| Martinelli et al[ | 49 | 98 | 30:19 | 10.7 | 7–14 | Tournier | ST | Ti | N | TA = 12 | WC 2/52 | 59 | N | |
| Cao et al[ | 20 | 27 | 12:8 | 12.1 | 7–16 | Integra | ST | Ti + P | N | WB 12/52 | 28.1 | Y | SM | |
| Das et al[ | 15 | 25 | 10:5 | 12.5 | C | SS/Ti | N | TA = 7 | FWB | 54 | Y | 36/12 | ||
| Giannini et al[ | 44 | 88 | 31:13 | 11.7 | 8–14 | Lima | C | PLLA | Y | TA = 24 | WC 2/52 | 48 | N | |
| Arbab et al[ | 41 | 73 | 23:18 | 11.8 | 9–14 | C | SS | N | 30.6 | N | ||||
| Caravaggi et al[ | 13 | 13 | 11.3 | ST/C | PLLA | Y | 12.5 | N | ||||||
| Indino et al[ | 56 | 112 | 34:22 | Tornier; BRM | ST | Ti | N | None | WC 2/52 | 40 | N | |||
| Memeo et al[ | 402 | 13.4 | 8–16 | ST/C | PLLA/Ti | Y/N | TA = 327 | NWB 2/52 | 30.6 | N | ||||
| De Bot et al[ | 16 | 26 | 10:6 | 12.5 | 10–15 | Integra | ST | Ti + P | N | TA = 20, SL = 14 | NWB 4/52, WC 4/52 | 47 | Y | 34/12 |
| Ruiz-Picazo et al[ | 16 | 32 | 13:3 | 9.0 | 7–11 | ST | Ti | N | None | 12 | Y | SM | ||
| Megremis & Megremis[ | 14 | 28 | 10:4 | 10.7 | 8–14 | Integra | ST | Ti | N | TA = 28 | NWB 2/52, WC 2/52 | 35 | N | |
| Papamerkouriou et al[ | 6 | 12 | 11.05 | 6–15 | Integra | ST | Ti + P | N | None | WC 4/52 | 6 | Y | 18/12 | |
| Hagen et al[ | 14 | 27 | 12:2 | 12.38 | Synthes | C | SS | N | 1 | N | ||||
| Bernasconi et al[ | 31 | 62 | 22:19 | 10.5 | 8–15 | Stryker | ST | SS | N | FWB after 2/7 | 62.5 | N | ||
| Kubo et al[ | 50 | 95 | 11.3 | 5–15 | C | N | TA = 35 | FWB | 35.8 | N | ||||
| Franz et al[ | 39 | 78 | 11.3 | C | SS | N | TA = 11 | 6 | N |
Notes. ST = sinus tarsi; C = calcaneum; T = talus; PLLA = poly-L-lactic acid; SS = stainless steel; Ti = titanium alloy; P = ultra high molecular weight polyethylene; TA = tendo-Achilles or triceps surae soft tissue procedure; AN = accessory navicular excision; SL = spring ligament reconstruction; FWB = full weight-bearing; PWB = partial weight-bearing; WB = walking boot; WC = walking cast; /52 = weeks; SM = skeletal maturity; F = formula (age in years x2)+6 = months; M = months.
Pre- and post-operative radiological outcomes
| Outcome | MCB | LTCJ | CI | LT1M | APT1M | APTN | APTC | TD |
|---|---|---|---|---|---|---|---|---|
| Studies | 8 | 7 | 13 | 16 | 4 | 4 | 8 | 7 |
| No of feet | 1736 | 434 | 2017 | 703 | 99 | 176 | 1122 | 1736 |
| Pre-op mean | 145.3° | 42.4° | 12.2° | 17.1° | 22.2° | 21.3° | 31.2° | 40.1° |
| Post-op mean | 129.2° | 36.4° | 15.7° | 7.4° | 9.1° | 12.5° | 24.5° | 27.2° |
| Difference | –16.1° | –6.0° | +3.5° | +9.7° | –13.1° | –8.8° | –6.6° | –12.9° |
| Normal range | 115–125° | 25–45° | 13–23° | 2–10° | 3–11° | 0–7° | 15–27° | 18–24° |
Notes. Values in the normal range are denoted by underlined bold text. MCB = Moreau-Costa-Bertini angle; LTCJ = lateral talar calcaneal joint angle; CI = calcaneal inclination; LT1M = lateral talar 1st metatarsal angle; APT1M = anterior-posterior talar 1st metatarsal angle; APTN = anterior-posterior talar navicular angle; APTC = anterior-posterior talar calcaneal angle; TD = talar declination.
Pre- and post-operative kinematic outcomes
| Outcome | Hindfoot valgus (M) | Hindfoot valgus (C) | Forefoot abduction (C) | Subtalar supination | Dorsiflexion | Viladot grade |
|---|---|---|---|---|---|---|
| Studies | 4 | 2 | 2 | 1 | 3 | 3 |
| No of feet | 112 | 1142 | 1142 | 25 | 67 | 130 |
| Pre-op mean | 11.9° | 100.0% | 65.2% | 6.7° | 11.3° | 2.7 |
| Post-op mean | 3.9° | 1.0% | 3.1% | 14.5° | 16.4° | 0.6 |
| Difference | –8.1° | 99.0% | 62.1% | +7.8° | +5.1° | −2.1 |
Notes. (M) = measured value; (C) = clinical opinion.
Pre- and post-operative clinical outcomes
| Outcome | VAS | VAS-FA | MOXFQ | AOFAS | OAFQC -P | OAFQC -S | OAFQC -E | OAFQC -F |
|---|---|---|---|---|---|---|---|---|
| Studies | 3 | 2 | 1 | 3 | 3 | 3 | 3 | 2 |
| No. of feet | 53 | 56 | 12 | 52 | 155 | 155 | 155 | 130 |
| Pre-op mean | 5.5 | 70.3 | 55.3 | 57.6 | 66.9 | 86.1 | 83.6 | 69.9 |
| Post-op mean | 1.4 | 85.1 | 34.3 | 80.4 | 72.8 | 90.0 | 90.9 | 80.7 |
| Difference | −4.1 | 14.9 | −21.0 | +22.6 | +5.9 | +3.9 | +7.2 | +10.9 |
Notes. VAS = visual analogue scale [of pain]; VAS-FA = visual analogue scale foot and ankle; MOXFQ = Manchester-Oxford foot questionnaire; AOFAS = American Orthopaedic foot and ankle score; OAFQC = Oxford ankle foot questionnaire for children; -P = physical; -S = school and play; - E = emotional; -F = footwear.